3 Results for "

SARS-CoV-2 3CLpro-IN-6

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "SARS-CoV-2 3CLpro-IN-6" in MCE Product Catalog:

Cat. No.: HY-152005
CAS No.: 302821-53-0
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 3CLpro-IN-6 is a reversible covalent inhibitor of SARS-CoV-2 3CL protease. SARS-CoV-2 3CLpro-IN-6 has potent inhibitory activity for SARS-CoV-2 3CL pro with an IC50 value of 4.9 μM. SARS-CoV-2 3CLpro-IN-6 can be used for the research of coronavirus disease 2019 (COVID-19) .
loading...
    loading...
Cat. No.: HY-175029
CAS No.: 2892287-29-3
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

ALG-097558 is an orally active 3CLpro inhibitor. ALG-097558 demonstrates pan-coronavirus activity against various SARS-CoV-2 variants as well as other human coronaviruses (HCoVs) such as SARS-CoV-1, α-HCoV 229E, and β-HCoV OC43. ALG-097558 demonstrates potent inhibition with IC50s of 2 nM (SARS-CoV-2 3CLpro) and 6 nM (229E 3CLpro). ALG-097558 demonstrates antiviral activity in the SARS-CoV-2 hamster infection model. ALG-097558 can be used for the study of viral infections[1].
loading...
    loading...
Cat. No.: HY-10237S
CAS No.: 1256751-11-7
Synonyms: EBP 520-d9; SCH 503034-d9
Boceprevir-d9 is the deuterium labeled Boceprevir. Boceprevir (EBP 520) is a potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with a Ki of 14 nM in both enzyme assay and an EC90 of 350 nM in cell-based replicon assay . Boceprevir inhibits SARS-CoV-2 3CLpro activity .
loading...
    loading...